Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 9/20 | 0.45 |
| ▸ | LTC4S | Q16873 | 4/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 6/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4498143 | 0.92 | CETP (0.38) | CETPLTC4SCRHR1AR | |
| SCHEMBL4490321 | 0.91 | CETP (0.43) | CETPLTC4SCRHR1AR | |
| SCHEMBL130241 | 0.87 | CETP (0.40) | CETPLTC4SCRHR1AR | |
| SCHEMBL4496365 | 0.86 | CETP (0.43) | CETPLTC4SCRHR1 | |
| SCHEMBL4495615 | 0.86 | AR (0.35) | CETPLTC4SCRHR1AR | |
| SCHEMBL4493484 | 0.85 | CETP (0.43) | CETPLTC4SCRHR1AR | |
| SCHEMBL1588409 | 0.84 | CETP (0.46) | CETPLTC4SAR | |
| SCHEMBL1588099 | 0.84 | CETP (0.45) | CETPLTC4SAR | |
| SCHEMBL22205111 | 0.81 | CETP (0.44) | CETPLTC4S | |
| SCHEMBL4493410 | 0.79 | CYSLTR2 (0.38) | CETPLTC4SCRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023729-A1 | Trisubstituted amine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023729-A1 | Trisubstituted amine compound | CETP, MTTP, APOB | CETP 1/4885LTC4S 385/4885CRHR1 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.